Choroidal Changes Post Short Term Exposure To Virtual Reality Devices

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2020-07-31

Study Completion Date

2021-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a prospective, randomized, controlled, contralateral eye, clinical study. The objective of the study is to determine the impact of Virtual Reality (VR) usage on choroidal thickness when viewed through a test display compared to a control (standard) VR display. The hypothesis is that there will be less choroidal thinning in the eye viewing the test VR screen compared to the eye viewing the control VR screen.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Comparing Vision Tests in a Virtual Reality Headset to Existing Analogues

NCT04714424

Ptosis Macular Degeneration Ametropia

COMPLETED

Developing and Validating VR-Enabled Ophthalmic Clinics: A New Paradigm for Visual Function Testing

NCT04530773

Visual Health of Virtual Reality

COMPLETED NA

Effect of Virtual Reality-Based Visual Training for Myopia Control in Children

NCT06250920

Myopia Myopia, Progressive

COMPLETED NA

Effectiveness of Virtual Reality Training in Amblyopia

NCT05732467

Amblyopia

UNKNOWN NA

The Effects of Low Dose Atropine on Choroidal Thickness

NCT03544827

Myopia

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Myopia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomized, contralateral eye study

Primary Study Purpose

PREVENTION

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Visu OD, Control OS

Contralateral eye study

Group Type OTHER

Visu

Intervention Type DEVICE

An experimental (test) virtual reality display

Control OD, Visu OS

Contralateral eye study

Group Type OTHER

Visu

Intervention Type DEVICE

An experimental (test) virtual reality display

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Visu

An experimental (test) virtual reality display

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Is at least 13 years of age and has full legal capacity to volunteer;
* Has read and signed an information consent letter;
* Visual Acuity of +0.20 logMAR or better in each eye;
* Is willing and able to follow instructions and maintain the appointment schedule.

Exclusion Criteria

* Is participating in any concurrent clinical or research study;
* Has any known active ocular disease and/or infection;
* Has a systemic condition that in the opinion of the investigator may affect a study outcome variable;
* Is amblyopic in either eye;
* Has a colour vision abnormality;
* Commonly experiences motion sickness.

Minimum Eligible Age

13 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes